Im SA - Search Results

1

Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1⁺ Activated T Cells.

Dovedi SJ, Elder MJ, Yang C, Sitnikova SI, Irving L, Hansen A, Hair J, Jones DC, Hasani S, Wang B, Im SA, Tran B, Subramaniam DS, Gainer SD, Vashisht K, Lewis A, Jin X, Kentner S, Mulgrew K, Wang Y, Overstreet MG, Dodgson J, Wu Y, Palazon A, Morrow M, Rainey GJ, Browne GJ, Neal F, Murray TV, Toloczko AD, Dall'Acqua W, Achour I, Freeman DJ, Wilkinson RW, Mazor Y. Dovedi SJ, et al. Among authors: im sa. Cancer Discov. 2021 May;11(5):1100-1117. doi: 10.1158/2159-8290.CD-20-1445. Epub 2021 Jan 8. Cancer Discov. 2021. PMID: 33419761

2

Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.

Lee KW, Kim SG, Kim HP, Kwon E, You J, Choi HJ, Park JH, Kang BC, Im SA, Kim TY, Kim WH, Bang YJ. Lee KW, et al. Among authors: im sa. Cancer Res. 2008 Mar 15;68(6):1916-26. doi: 10.1158/0008-5472.CAN-07-3195. Cancer Res. 2008. PMID: 18339873

3

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.

Yoon YK, Kim HP, Han SW, Hur HS, Oh DY, Im SA, Bang YJ, Kim TY. Yoon YK, et al. Among authors: im sa. Mol Cancer Ther. 2009 Sep;8(9):2526-36. doi: 10.1158/1535-7163.MCT-09-0300. Epub 2009 Sep 15. Mol Cancer Ther. 2009. PMID: 19755509

4

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.

Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY. Han SW, et al. Among authors: im sa. Cancer Sci. 2010 Mar;101(3):793-9. doi: 10.1111/j.1349-7006.2009.01447.x. Epub 2009 Nov 23. Cancer Sci. 2010. PMID: 20047592 Free article. Clinical Trial.

5

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy.

Yhim HY, Han SW, Oh DY, Han W, Im SA, Kim TY, Kim YT, Noh DY, Chie EK, Ha SW, Park IA, Bang YJ. Yhim HY, et al. Among authors: im sa. Cancer. 2010 Jun 15;116(12):2890-901. doi: 10.1002/cncr.25054. Cancer. 2010. PMID: 20564396 Free article.

6

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer.

Nam HJ, Kim HP, Yoon YK, Hur HS, Song SH, Kim MS, Lee GS, Han SW, Im SA, Kim TY, Oh DY, Bang YJ. Nam HJ, et al. Among authors: im sa. Cancer Lett. 2011 Mar 28;302(2):155-65. doi: 10.1016/j.canlet.2011.01.010. Cancer Lett. 2011. PMID: 21306821

7

Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins.

Lee KH, Lee JH, Han SW, Im SA, Kim TY, Oh DY, Bang YJ. Lee KH, et al. Among authors: im sa. Cancer Sci. 2011 Jul;102(7):1388-95. doi: 10.1111/j.1349-7006.2011.01944.x. Epub 2011 May 3. Cancer Sci. 2011. PMID: 21453385 Free article.

8

Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.

Park J, Park E, Han SW, Im SA, Kim TY, Kim WH, Oh DY, Bang YJ. Park J, et al. Among authors: im sa. Invest New Drugs. 2012 Aug;30(4):1404-12. doi: 10.1007/s10637-011-9710-9. Epub 2011 Jul 1. Invest New Drugs. 2012. PMID: 21720740

9

Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells.

Yoon YK, Kim HP, Song SH, Han SW, Oh DY, Im SA, Bang YJ, Kim TY. Yoon YK, et al. Among authors: im sa. Cancer Lett. 2012 Mar;316(1):77-84. doi: 10.1016/j.canlet.2011.10.023. Epub 2011 Oct 23. Cancer Lett. 2012. PMID: 22082529

10

Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer.

Nam HJ, Ching KA, Kan J, Kim HP, Han SW, Im SA, Kim TY, Christensen JG, Oh DY, Bang YJ. Nam HJ, et al. Among authors: im sa. Mol Cancer Ther. 2012 Feb;11(2):439-51. doi: 10.1158/1535-7163.MCT-11-0494. Epub 2011 Dec 1. Mol Cancer Ther. 2012. PMID: 22135232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page